Showing 34,912 results

Filters
PrEP science

HIV PrEP Study Finds Modest Bone Loss on FTC/TDF Compared to Cabotegravir

Editor's pick
TheBodyPro
16 July 2025
HIV treatment for children & young people

Childhoods at Risk: 2025 HIV Data Reveal an Urgent Crisis

Editor's pick
Partnership for Maternal Newborn and Child Health
16 July 2025
Transgender people

What To Know About Prescribing Gender-Affirming Hormone Therapy With HIV Treatment

Editor's pick
TheBodyPro
16 July 2025
Injectable & long-acting PrEP

WHO recommends injectable lenacapavir for HIV prevention

Editor's pick
World Health Organization
16 July 2025
Access to healthcare

US: The Coming HIV Care Crisis

Editor's pick
HIV-HCV Co-Infection Watch
16 July 2025
Harm reduction

Syringe Programs Boost Hepatitis C Treatment for People Who Inject Drugs

Editor's pick
POZ
16 July 2025
Injectable & long-acting PrEP

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Editor's pick
Merck press release
16 July 2025
HIV & criminal law

New global data reveals rising HIV criminalisation amid stalling legal reforms

Editor's pick
HIV Justice Network
16 July 2025
Injectable & long-acting PrEP

New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention

Editor's pick
ITPC Global
16 July 2025
Government, leadership & policy

Francois Venter | Slow motion denialism: South Africa's leaders are allowing the HIV response to collapse

Editor's pick
Spotlight
16 July 2025
Travel

Global study reveals 50 countries still enforce HIV-related travel restrictions

Editor's pick
HIV Justice Network
16 July 2025
HIV vaccine & cure research

Engineered T-cells may kill off reservoir cells, mimicking elusive CD8 vaccine effect

News
16 July 2025
Sexually transmitted infections prevention

Resistance is a growing concern amid rising use of doxyPEP

News
16 July 2025

IAS 2025: HIV funding crisis the focus of IAS 2025, 16 July 2025

July 2025
Finance & funding

“We will not go back!”: a powerful, resolute response to funding cuts at IAS 2025

News
16 July 2025
Government, leadership & policy

Rwanda’s HIV leadership on display at IAS 2025

News
16 July 2025
Global health initiatives

Global AIDS funding to be pulled from Trump clawbacks request

Editor's pick
POLITICO
15 July 2025
Injectable & long-acting HIV treatment

ViiV Healthcare and Medicines Patent Pool extend voluntary licensing agreement to enable access to long-acting injectable HIV treatment

Editor's pick
Medicines Patent Pool
15 July 2025
HIV treatment

How treatment works Illustrated

About HIV
July 2025
Access to healthcare

Dutch survey finds informal use of doxyPEP is rising

Editor's pick
CIDRAP
10 July 2025
Pharmaceutical industry

HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak

Editor's pick
FiercePharma
10 July 2025
Conference announcements & declarations

IAS 2025 Preview: Amidst a Worldwide Funding Emergency, HIV Science Moves Forward

Editor's pick
TheBodyPro
10 July 2025
PEP

2025 Updates to US HIV nPEP Guidelines: Many Welcome Changes—and One Concern

Editor's pick
TheBodyPro
10 July 2025
Cardiovascular disease

Popular HIV Drug Linked to Higher Risk for MACE

Editor's pick
Medscape (requires free registration)
10 July 2025